PIVKA-II levels exceeding the 40 mAU/mL cutoff value were found in six patients (1.8%), whose tumors were ruled out as HCC by the follow-up studies of changes in findings on US and CT, and of PIVKA-II and AFP levels. The gene discussed is AFP; the disease is hepatocellular carcinoma.